Neogene Therapeutics

Acquired

Pushing the frontier by pioneering next-generation engineered T cell receptor therapies for solid cancers

Amsterdam, Netherlands · Founded 2018 · $125.0M raised

Headquarters
Amsterdam
Employees
51–200
Founded
2018
Business Model
B2B
Total Funding
$125.0M
Last Round
$110.0M Series ASep 2020
Rounds
2
Acquired by
AstraZeneca PLCJan 2023 · $200.0M

About

Neogene Therapeutics is a global clinical-stage biotechnology company pioneering the discovery, development, and manufacturing of next-generation engineered T cell receptor (TCR) therapies targeting a broad spectrum of solid cancers. With offices in Amsterdam and Santa Monica, Neogene aims to change the treatment paradigm for solid tumors. Acquired by AstraZeneca in January 2023, it operates as a wholly owned subsidiary.

Summary

Neogene Therapeutics is a Biotech company based in Amsterdam, Netherlands, founded in 2018. It has raised $125.0M in total across 2 rounds, most recently a $110.0M Series A round in Sep 2020. Investors include AstraZeneca, EcoR1 Capital and Jeito Capital.

Funding History

AcquisitionJan 2023

Sign up to see all 4 rounds

Seed through Acquisition — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Neogene Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/neogene-therapeutics"><img src="https://indexed.vc/api/badge/company/neogene-therapeutics" alt="Neogene Therapeutics on Indexed.vc" width="260" height="76" /></a>